Navigation Links
Suppression of Enzyme Delays a Type of Breast Cancer

Canadian researchers have disclosed that suppression of an enzyme called PTP1B stalls the advancement of a specific type of breast cancer//. This study was conducted on laboratory mice which were genetically modified to develop into a breast cancer condition of humans.

This research headed by Michel L.Tremblay along with Sophie Julien of McGill cancer Center, Quebec delayed the advancement of a particular kind of breast cancer linked to ERBB2 gene. In this case, the breast tumor appeared almost eight weeks later and lung metastases did not happen. In some mice cancer did not develop at all.

On the other hand, when the enzyme PTP1B was expressed it resulted in the development of cancer. Understanding of the relationship between this enzyme and breast cancer is likely to go a long way in treatment of this disease.

Clinical trials of a drug with inhibitory reaction to this protein are underway. There is already a research finding which claims that diabetes 2 and obesity can be treated by this enzyme suppression. In addition to this, PTP1B inhibitors have been developed by drug companies too.

Testing of this inhibitor on humans could begin by 2008. These inhibitors alone or along with another drug could be used in the treatment of breast cancer patients. Currently Herceptin or Trastuzumab is being used.

According to these scientists though there is lot of work to be done in this field, this finding is sure to have a positive impact on further research in this topic.


JYT
'"/>




Page: 1

Related medicine news :

1. Adrenal Suppression not predicted by inhaled corticosteroids
2. Transplant Cures Rats’ Type 2 Diabetes without Need for Immune Suppression Drug
3. Long-time Gastric Acid Suppression Does Not Increase The Risk Of Cancer
4. Should Menstrual Suppression Be a Lifestyle Choice?
5. Enzyme may be target for obesity drugs
6. Researchers trick Alzheimers Enzyme
7. Enzyme stimulates growth of adult stem cells
8. Enzyme may aid hold back disease
9. Enzyme help destroy cancer cell
10. Enzyme Associated with Memory
11. Enzyme Associated With Memory
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... 19, 2017 , ... Attorney Robert “RC” Pate , founder of The ... the Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric ... firsthand the effect of the critical funding gap for research into pediatric cancer research. ...
(Date:1/19/2017)... ... ... Connecticut Dermatology Group (CDG) is proud and excited to welcome back to the ... brings an extensive background in cutting-edge dermatology care and research to Connecticut’s largest ... Kim to the CDG team” said President and Managing Partner Dr. Steven A. Kolenik ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
(Date:1/18/2017)... ... ... From a health perspective, 2017 will clearly be the Year of the Gut. ... health and general physical well-being. The New York Times suggested a “ Gut Makeover ... Charlottesville restaurant, good gut health is clearly on the menu. Threepenny Cafe ...
(Date:1/18/2017)... ... January 18, 2017 , ... The V Foundation for ... V, its official endurance training and fundraising team, to compete in the Boston Marathon ... those inspired to finish the world’s oldest annual marathon to join Team V and ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Aprima Medical ... records (EHR), practice management (PM) and revenue cycle ... the acquisition of a former reseller Healthcare Data ... of the agreement, Aprima will assume full support ... in 125 medical practices across 15 states. Financial ...
(Date:1/18/2017)... 18, 2017 The Philadelphia Pediatric Medical Device Consortium ... devices for children. The Consortium chose those companies ... of $50,000 each. The devices under development are ... a hand-operated rapid blood delivery system for emergency situations and ... ...
(Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... biotechnology company specializing in the development and commercialization of ... tissues and organs, recently reported the Company,s operating results ... 2017. As the Company described in its ... a year of substantial accomplishments. The Company,s contract laboratory ...
Breaking Medicine Technology: